2. Endometriehyperplasi, andre premaligne forandringer og metaplasier i endometriet

Abada, E., Banet, N., & Quddus, M. R. (2022). Variants of in situ carcinoma of the endometrium: Clear cell and gastrointestinal types, with a review of the literature. Gynecologic oncology reports, 44, 101078.

Anastasiadis, P. G., Koutlaki, N. G., Skaphida, P. G., Galazios, G. C., Tsikouras, P. N., & Liberis, V. A. (2000). Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. European Journal of Gynaecological Oncology, 21(2), 180-3.

Baak, J. P., Mutter, G. L., Robboy, S., van Diest, P. J., Uyterlinde, A. M., Orbo, A., Palazzo, J., Fiane, B., ... Verheijen, R. H. (2005). The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer, 103(11), 2304-12.

Baak, J. P., Nauta, J. J., Wisse-Brekelmans, E. C., & Bezemer, P. D. (1988). Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. Journal of Pathology, 154(4), 335-41.

Baak, J. P., Wisse-Brekelmans, E. C., Fleege, J. C., van der Putten, H. W., & Bezemer, P. D. (1992). Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features. Pathology, Research and Practice, 188(7), 856-9.

Baak, J. P., Ørbo, A., van Diest, P. J., Jiwa, M., de Bruin, P., Broeckaert, M., Snijders, W., Boodt, P. J., ... Kenemans, P. (2001). Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. American Journal of Surgical Pathology, 25(7), 930-5.

Berceanu, C., Cernea, N., Comănescu, A. C., Paitici, Ş., Rotar, I. C., ... Olinca, M. V. (2022). Endometrial polyps. Romanian Journal of Morphology and Embryology, 63(2), 323-334.

Bjerre Trent, P. K., Nordskar, N. J., Wangen, K. R., Engeskaug, M. I., Opheim, M., Aune, G., Staff, A. C., Thorsen, L., ... Eriksson, A. G. Z. (2023). Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study. Gynecologic Oncology, 175, 72-80.

Buchanan, D. D., Rosty, C., Clendenning, M., Spurdle, A. B., & Win, A. K. (2014). Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome). Appl Clin Genet, 7, 183-93.

Chen, H., Strickland, A. L., & Castrillon, D. H. (2022). Histopathologic diagnosis of endometrial precancers: Updates and future directions. Seminars in Diagnostic Pathology, 39(3), 137-147.

Cohen, I. (2004). Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecologic Oncology, 94(2), 256-66.

Committee on Gynecologic Practice, ,. S. o. G. O. (2015). The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstetrics and Gynecology, 125(5), 1272-8.

Crissman, J. D., Azoury, R. S., Barnes, A. E., & Schellhas, H. F. (1981). Endometrial carcinoma in women 40 years of age or younger. Obstetrics and Gynecology, 57(6), 699-704.

De Rocco, S., Buca, D., Oronzii, L., Petrillo, M., Fanfani, F., Nappi, L., Liberati, M., D'Antonio, F., ... Lucidi, A. (2022). Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 273, 90-97.

Dijkhuizen, F. P., Mol, B. W., Brolmann, H. A., & Heintz, A. P. (2000). The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer, 89(8), 1765-72.

Dunton, C. J., Baak, J. P., Palazzo, J. P., van Diest, P. J., McHugh, M., & Widra, E. A. (1996). Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. American Journal of Obstetrics and Gynecology, 174(5), 1518-21.

Furness, S., Roberts, H., Marjoribanks, J., & Lethaby, A. (2012). Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database of Systematic Reviews, (8), CD000402.

Gallos, I. D., Krishan, P., Shehmar, M., Ganesan, R., & Gupta, J. K. (2013). Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up. Human Reproduction, 28(5), 1231-6.

Gallos, I. D., Shehmar, M., Thangaratinam, S., Papapostolou, T. K., Coomarasamy, A., & Gupta, J. K. (2010). Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 203(6), 547.e1-10.

Gull, B., Karlsson, B., Milsom, I., & Granberg, S. (2003). Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. American Journal of Obstetrics and Gynecology, 188(2), 401-8.

Hui, P., Kelly, M., O'Malley, D. M., Tavassoli, F., & Schwartz, P. E. (2005). Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Modern Pathology, 18(1), 75-82.

Judd, H. L., Mebane-Sims, I., Legault, C., Wasilauskas, C., Johnson, S., Merino, M., Barrett-Connor, E., Trabal, J., ... Scully, R. (1996). Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 275(5), 370-375.

Kandoth, C., Schultz, N., Cherniack, A. D., Akbani, R., Liu, Y., Shen, H., Robertson, A. G., Pashtan, I., ... Levine, D. A. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67-73.

Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985). The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer, 56(2), 403-12.

Lacey, J. V. ,. J., Sherman, M. E., Rush, B. B., Ronnett, B. M., Ioffe, O. B., Duggan, M. A., Glass, A. G., Richesson, D. A., ... Langholz, B. (2010). Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. Journal of Clinical Oncology, 28(5), 788-92.

Larsen, I. K. (2024). Cancer in Norway 2023: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Leitao, M. M. ,. J., Zhou, Q. C., Gomez-Hidalgo, N. R., Iasonos, A., Baser, R., Mezzancello, M., Chang, K., Ward, J., ... Abu-Rustum, N. R. (2020). Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecologic Oncology, 156(1), 147-153.

Lieng, M., Qvigstad, E., Sandvik, L., Jørgensen, H., Langebrekke, A., & Istre, O. (2007). Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. Journal of Minimally Invasive Gynecology, 14(2), 189-94.

Lin, M. C., Lomo, L., Baak, J. P., Eng, C., Ince, T. A., Crum, C. P., & Mutter, G. L. (2009). Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Modern Pathology, 22(2), 167-74.

McCluggage, W. G. (2006). My approach to the interpretation of endometrial biopsies and curettings. Journal of Clinical Pathology, 59(8), 801-12.

Mittermeier, T., Farrant, C., & Wise, M. R. (2020). Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database of Systematic Reviews, 9(9), Cd012658.

Monte, N. M., Webster, K. A., Neuberg, D., Dressler, G. R., & Mutter, G. L. (2010). Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Research, 70(15), 6225-32.

Mooney, S. S., & Sumithran, P. (2023). Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 288, 49-55.

Mueller, J. J., Rios-Doria, E., Park, K. J., Broach, V. A., Alektiar, K. M., Jewell, E. L., Zivanovic, O., Sonoda, Y., ... Gardner, G. J. (2023). Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon?. Gynecologic Oncology, 168, 1-7.

Mutter, G. L., Baak, J. P., Crum, C. P., Richart, R. M., Ferenczy, A., & Faquin, W. C. (2000). Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. Journal of Pathology, 190(4), 462-9.

Mutter, G. L., Ince, T. A., Baak, J. P., Kust, G. A., Zhou, X. P., & Eng, C. (2001). Molecular identification of latent precancers in histologically normal endometrium. Cancer Research, 61(11), 4311-4.

Mutter, G. L., Zaino, R. J., Baak, J. P., Bentley, R. C., & Robboy, S. J. (2007). Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. International Journal of Gynecological Pathology, 26(2), 103-14.

Natarajan, P., Vinturache, A., Hutson, R., Nugent, D., & Broadhead, T. (2020). The value of MRI in management of endometrial hyperplasia with atypia. World Journal of Surgical Oncology, 18(1), 34.

Nilsson, C. G., Haukkamaa, M., Vierola, H., & Luukkainen, T. (1982). Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clinical Endocrinology, 17(6), 529-36.

Park, B., Lee, H., Park, S., Lee, E. S., Lee, J. J., Lee, Y., & Seo, J. H. (2022). Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database. BMC Women's Health, 22(1), 439.

Reed, S. D., Newton, K. M., Clinton, W. L., Epplein, M., Garcia, R., Allison, K., Voigt, L. F., & Weiss, N. S. (2009). Incidence of endometrial hyperplasia. American Journal of Obstetrics and Gynecology, 200(6), e1-e6.

Rodolakis, A., Scambia, G., Planchamp, F., Acien, M., Di Spiezio Sardo, A., Farrugia, M., Grynberg, M., Pakiz, M., ... Macklon, K. L. T. (2023). ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma(). Human Reproduction Open, 2023(1), hoac057.

Schmeler, K. M., Daniels, M. S., Brandt, A. C., & Lu, K. H. (2009). Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome. Obstetrics and Gynecology, 114(2 Pt 2), 477-9.

Simon, R. A., Peng, S. L., Liu, F., Quddus, M. R., Zhang, C., Steinhoff, M. M., Lawrence, W. D., & Sung, C. J. (2011). Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, Ki-67, TERT, and long-term follow-up. Modern Pathology, 24(9), 1254-61.

Slaager, C., Hofhuis, W., Hoogduin, K., Ewing-Graham, P., & van Beekhuizen, H. (2021). Serous endometrial intraepithelial carcinoma (SEIC): Current clinical practice in The Netherlands. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 265, 25-29.

Sletten, E. T., Arnes, M., Vereide, A. B., & Orbo, A. (2018). Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study. Anticancer Research, 38(5), 2883-2889.

Tingthanatikul, Y., Choktanasiri, W., Rochanawutanon, M., & Weerakeit, S. (2006). Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecological Endocrinology, 22(2), 101-5.

Trimble, C. L., Kauderer, J., Zaino, R., Silverberg, S., Lim, P. C., Burke, J. J. ,. 2., Alberts, D., & Curtin, J. (2006). Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer, 106(4), 812-9.

Turashvili, G., & Childs, T. (2015). Mucinous metaplasia of the endometrium: current concepts. Gynecologic Oncology, 136(2), 389-93.

Vakiani, M., Vavilis, D., Agorastos, T., Stamatopoulos, P., Assimaki, A., & Bontis, J. (1996). Histopathological findings of the endometrium in patients with dysfunctional uterine bleeding. Clinical and Experimental Obstetrics and Gynecology, 23(4), 236-9.

WHO Classification of Tumours Editorial Board (2020). Female Genital Tumours. International Agency for Research on Cancer.

WHO Classification of Tumours Editorial Board (2020). Tumours of the uterine corpus. Endometrial polyp. I: Female Genital Tumours. International Agency for Research on Cancer.

WHO Classification of Tumours Editorial Board (2020). Tumours of the uterine corpus. Precursor lesions. I: Female Genital Tumours. International Agency for Research on Cancer.

Wise, M. R., Jordan, V., Lagas, A., Showell, M., Wong, N., Lensen, S., & Farquhar, C. M. (2016). Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. American Journal of Obstetrics and Gynecology, 214(6), 689.e1-689.e17.

Zanagnolo, V., Pasinetti, B., & Sartori, E. (2004). Clinical review of 63 cases of sex cord stromal tumors. European Journal of Gynaecological Oncology, 25(4), 431-8.

Ørbo, A., Arnes, M., Hancke, C., Vereide, A. B., Pettersen, I., & Larsen, K. (2008). Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecologic Oncology, 111(1), 68-73.

Ørbo, A., Arnes, M., Vereide, A. B., & Straume, B. (2016). Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG: An International Journal of Obstetrics and Gynaecology, 123(9), 1512-9.

Ørbo, A., Baak, J. P., Kleivan, I., Lysne, S., Prytz, P. S., Broeckaert, M. A., Slappendel, A., & Tichelaar, H. J. (2000). Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway. Journal of Clinical Pathology, 53(9), 697-703.

Ørbo, A., Vereide, A., Arnes, M., Pettersen, I., & Straume, B. (2014). Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. BJOG: An International Journal of Obstetrics and Gynaecology, 121(4), 477-86.